Protocol for a 30-day randomised, parallel-group, non-inferiority, controlled trial investigating th...
Protocol for a 30-day randomised, parallel-group, non-inferiority, controlled trial investigating the effects of discontinuing renin-angiotensin system inhibitors in patients with and without COVID-19: the RASCOVID-19 trial
About this item
Full title
Author / Creator
Kliim-Hansen, Vivian , Gasbjerg, Lærke Smidt , Ellegaard, Anne-Marie , Lorentsson, Hans Johan Niklas , Lynggaard, Mads Bank , Hagemann, Christoffer Andersen , Legart, Christian , Mathiesen, David Siersbæk , Sivapalan, Pradeesh , Jensen, Jens-Ulrik Stæhr , Vilsbøll, Tina , Christensen, Mikkel Bring and Knop, Filip Krag
Publisher
England: British Medical Journal Publishing Group
Journal title
Language
English
Formats
Publication information
Publisher
England: British Medical Journal Publishing Group
Subjects
More information
Scope and Contents
Contents
IntroductionThe COVID-19 pandemic caused by the virus SARS-CoV has spread rapidly and caused damage worldwide. Data suggest a major overrepresentation of hypertension and diabetes among patients experiencing severe courses of COVID-19 including COVID-19-related deaths. Many of these patients receive renin-angiotensin system (RAS) inhibiting therapy...
Alternative Titles
Full title
Protocol for a 30-day randomised, parallel-group, non-inferiority, controlled trial investigating the effects of discontinuing renin-angiotensin system inhibitors in patients with and without COVID-19: the RASCOVID-19 trial
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_dcbb7033f47c4536927aac2accbd5acc
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dcbb7033f47c4536927aac2accbd5acc
Other Identifiers
ISSN
2044-6055
E-ISSN
2044-6055
DOI
10.1136/bmjopen-2022-062895
